In silico SARS-CoV-2 vaccine development for Omicron strain using reverse vaccinology

BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic began in 2019 but it remains as a serious threat today. To reduce and prevent spread of the virus, multiple vaccines have been developed. Despite the efforts in developing vaccines, Omicron strain of the virus has...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Vladimir, Lee, Chul, Yoo, DongAhn, Cho, Seoae, Kim, Heebal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166176/
https://www.ncbi.nlm.nih.gov/pubmed/35665465
http://dx.doi.org/10.1007/s13258-022-01255-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166176/
https://www.ncbi.nlm.nih.gov/pubmed/35665465
http://dx.doi.org/10.1007/s13258-022-01255-8

Ejemplares similares